Stockreport

Allogene Therapeutics Inc (ALLO) Q3 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report
PDF The consensus estimate for Q3 2024 revenue is $0.01 million, and the earnings are expected to come in at -$0.33 per share. The full year 2024's revenue is expected to be [Read more]